-
LONDON: Indian-Origin Principal Wins UK Legal Challenge Over School Prayer Ban - 2 hours ago
-
TORONTO: Indian-Origin Doctor Needs ₹ 2 Crore For Legal Fees. Elon Musk Responds - 1 day ago
-
LONDON: UK Court Allows Sale Of Nirav Modi’s Luxury London Apartment - April 21, 2024
-
WASHINGTON: Meet Jigar Shah, Indian-American Named In TIME Most Influential List - April 20, 2024
-
LONDON: What Impact Will New UK Family Visa Rule Have On Indians - April 20, 2024
-
TORONTO: The American Dream: Why Indian Students Continue To Flock Abroad - April 19, 2024
-
CALIFORNIA: Infosys expands tie-up with Intel, to train its employees on company’s AI portfolio - April 19, 2024
-
TEXAS: Meet Gopi Thotakura, Indian Who Will Soon Go To The Edge Of Outer Space - April 18, 2024
-
NEW YORK: “Age Is Just A Number”: 99-Year-Old Indian Woman Granted US Citizenship - April 18, 2024
-
WASHINGTON: Indian-Americans Have Lowest Poverty Rate Among Asian Americans- Research - April 17, 2024
CAIRO : India offers support for Africa to fight the Omicron variant
CAIRO : We have noted the emergence of a new variant of Covid-19, Omicron. We express our solidarity with the countries, particularly in Africa, who have so far been affected by the Omicron variant.
The Government of India stands ready to support the countries affected in Africa in dealing with the Omicron variant, including by supplies of Made-in-India vaccines. Supplies can be undertaken through COVAX or bilaterally. In this regard, the Government has cleared all orders placed so far by COVAX for supplies of COVISHIELD vaccines including to African countries like Malawi, Ethiopia, Zambia, Mozambique, Guinea and Lesotho. We have also cleared supplies of COVAXIN to Botswana. Any new requirement projected either bilaterally or through COVAX will be considered expeditiously.
India also stands ready to supply essential life-saving drugs, test kits, gloves, PPE kits and medical equipment such as ventilators, as may be required. Indian institutions would favourably consider cooperation in genomic surveillance and virus characterization related research work with their African counterparts.
India has, so far, supplied more than 25 million doses of Made-in-India vaccines to 41 countries in Africa, including nearly 1 million doses as grant to 16 countries and more than 16 million doses under the COVAX facility to 33 countries.]